Julia Nowowiejska-Purpurowicz

33PUBLICATIONS
15CO-AUTHORS
Psychiatry (incl. psychotherapy)Medical biochemistry - proteins and peptides (incl. medical proteomics)Proteomics and intermolecular interactions (excl. medical proteomics)Molecular medicineProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 26, 2026
The Evaluation of the Clinical Effectiveness and Safety of Biologic Therapies in Psoriasis-Real-World Evidence up to 64 Weeks of Therapy.

|Aug 26, 2026
Matrix Metalloproteinase-9 (MMP-9) in Psoriasis: Integrating Extracellular Matrix Remodeling, Neutrophil-Endothelial Crosstalk and Biomarker Evidence.

|Jan 27, 2026
Plasma Galectin-7 (Gal-7) and Galectin-8 (Gal-8) as Emerging Biomarkers in Psoriasis: Associations with Disease Activity and Metabolic Status.

Julia Nowowiejska-Purpurowicz, Anna Baran, Justyna Magdalena Hermanowicz

|Jan 02, 2026
The molecular mechanism of the adverse effects of the biological and small molecular drugs in the therapy of inflammatory skin diseases - psoriasis and atopic dermatitis.

Patrycja Lemiesz, Julia Nowowiejska-Purpurowicz, Iwona Flisiak

|Dec 24, 2025
Antibodies Targeting Gasdermin E as a Potential Therapeutic Option for Psoriasis - A Pilot Study on a Mouse Model.

Julia Nowowiejska-Purpurowicz, Justyna M Hermanowicz, Dariusz Pawlak

|Nov 13, 2025
Plasma Galectin-4 and Charcot-Leyden Crystal Protein/Galectin-10 as Emerging Biomarkers of Metabolically Induced Inflammation in Patients with Psoriasis.

Anna Baran, Julia Nowowiejska, Julia Parzych

Pageof 6

Frequent Collaborators

17 joint publications

Anna Baran

9 joint publications

Dariusz Pawlak

8 joint publications

Justyna Magdalena Hermanowicz

7 joint publications

Tomasz W Kaminski